BioCentury
ARTICLE | Clinical News

Ushercell: Phase III data

August 11, 2008 7:00 AM UTC

Data from a double-blind, African and Indian Phase III trial in 1,398 HIV-negative women at high risk for HIV infection showed that there were 25 (5%) newly acquired HIV infections in the Ushercell gr...